Stock Price
2,616.50
Daily Change
14.00 0.54%
Monthly
-2.80%
Yearly
29.11%
Q2 Forecast
2,398.63

EPS Reference Time Actual Consensus Previous
2026-05-14 FY2026Q1 AM 32.43 30.05
2026-02-13 FY2025Q4 AM 55.18 59.02 29.30
2025-11-11 FY2025Q3 AM 61.72 53.21 27.22
2025-08-07 FY2025Q2 AM 35.18 50.24 38.67
2025-05-13 FY2025Q1 AM 30.05 29.26 31.98



Peers Price Chg Day Year Date
Nissui 1,359.50 -40.00 -2.86% 56.16% Apr/02
Maruha Nichiro 1,470.00 -29.50 -1.97% 35.53% Apr/02
Nisshin Seifun 2,156.50 6.50 0.30% 26.15% Apr/02
Meiji Holdings 3,949.00 26.00 0.66% 20.14% Apr/02
Nh Foods 7,376.00 86.00 1.18% 45.80% Apr/02
Sapporo 1,749.50 -4.00 -0.23% 20.08% Apr/02
Asahi 1,619.00 9.00 0.56% -15.15% Apr/02
Kirin Holdings 2,616.50 14.00 0.54% 29.11% Apr/02
Takara 1,609.50 16.50 1.04% 39.90% Apr/02
Kikkoman Corporation 1,545.50 22.00 1.44% 12.56% Apr/02

Indexes Price Day Year Date
JP225 52330 -1,276.41 -2.38% 50.65% Apr/02

Kirin Holdings traded at 2,616.50 this Thursday April 2nd, increasing 14.00 or 0.54 percent since the previous trading session. Looking back, over the last four weeks, Kirin Holdings gained 2.80 percent. Over the last 12 months, its price rose by 29.11 percent. Looking ahead, we forecast Kirin Holdings to be priced at 2,398.63 by the end of this quarter and at 2,097.05 in one year, according to Trading Economics global macro models projections and analysts expectations.

Kirin Holdings Company, Limited is a Japan-based company mainly engaged in the integrated beverage business and the pharmaceutical business. The Company operates in four business segments. The Domestic Beer and Spirits segment is engaged in the manufacture and sale of beer, low-malt beer, new genre products, wines and other liquor products in Japan. The Domestic Beverages segment is engaged in the manufacture and sale of soft drinks in Japan. The Oceania Integrated Beverages segment is engaged in the manufacture and sale of beer, wines, dairy products, juice drinks and other products in the Oceania region. The Pharmaceuticals segment is engaged in the manufacture and sale of pharmaceutical products. The Company is also engaged in the domestic wine business, the liquor business in Myanmar, the beverage business in North American, and the biochemical business.